Using the Cancer Genome Atlas Genomic Data Commons (TCGA GDC) datasets, we found that TRDV2 transcripts were detected in all 22 cancers evaluated (Figure S7A, top panel), with the highest expression in AML (n = 128 leukemias; Figure S7A, center panel). This evidence concerns the gene TRDV2 and leukemia.